The risk of switch to mania in patients with bipolar disorder during treatment with an antidepressant alone and in combination with a mood stabilizer.
about
The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise AlgorithmUse of large data sets and the future of personalized treatment.Self-poisoning suicide deaths in people with bipolar disorder: characterizing a subgroup and identifying treatment patterns.Bipolar II compared with bipolar I disorder: baseline characteristics and treatment response to quetiapine in a pooled analysis of five placebo-controlled clinical trials of acute bipolar depressionEvidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for PsychopharmacologyObsessive-Compulsive Disorder, Psychosis, and Bipolarity: A Longitudinal Cohort and Multigenerational Family StudySafety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective studyDo antidepressants increase the risk of mania and bipolar disorder in people with depression? A retrospective electronic case register cohort study.Short-term venlafaxine v. lithium monotherapy for bipolar type II major depressive episodes: effectiveness and mood conversion rate.Blood metabolomics analysis identifies abnormalities in the citric acid cycle, urea cycle, and amino acid metabolism in bipolar disorderMajor depression in primary care: making the diagnosis.Current psychotropic medication prescribing patterns in late-life bipolar disorder.Free Interval Duration: Clinical Evidence of the Primary Role of Excitement in Bipolar Disorder.Prescription Pattern of Antidepressants for Children and Adolescents in Korea Based on Nationwide DataDifferential failure to deactivate the default mode network in unipolar and bipolar depression.Prevalence of current anxiety disorders in people with bipolar disorder during euthymia: a meta-analysis.Psychopharmacological treatment of psychotic mania and psychotic bipolar depression compared to non-psychotic mania and non-psychotic bipolar depression.Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.Trends in the psychopharmacological treatment of bipolar disorder: a nationwide register-based study.Mitochondrial Agents for Bipolar Disorder.Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.Rethinking the spectrum of mood disorders: implications for diagnosis and management – Proceedings of a symposium presented at the 30th Annual European College of Neuropsychopharmacology Congress, 4 September 2017, Paris, France.
P2860
Q28066714-8AB86DC4-9928-485E-977A-6443941BC45DQ30870491-3D53BBCC-457D-4A48-AF85-E599FDF38094Q33606886-6F847737-E73C-4C45-8E6E-CC2F7DEFDBA4Q34518033-80562A70-2D83-446C-B858-3003FD25FCE1Q34676317-DE8DDABB-F21D-4EDF-872A-585BA4CDEBC8Q35950770-E3C6235B-0934-44A7-91DC-479CE696384DQ35967580-4024E93F-2833-43A1-8201-814A605FDE17Q36374021-E5AFFE63-3D2F-44F9-B08E-388732DF4B8EQ36754503-B6A09A04-F848-444E-B179-179CE11F4348Q36799359-5AF346E5-C438-4567-847E-34DD06A58FD3Q37672555-453E7385-68D9-4B14-9A5A-2D9A2DC6E032Q38788092-833CDA0A-677F-4E91-8B0C-55ABCB79F17BQ41638900-7B8164DA-3137-4094-AF78-0C92DEC4C6F3Q41649070-120D7C2B-ED74-4B60-9B3C-97236022948FQ47667124-76E88E2D-AF04-4318-ACA2-820703A72772Q47848081-8482747F-FDDE-4A47-BD35-5E265AFF94CEQ47863136-8EC3A4E7-AB9B-41A8-AEAB-225D17E213D7Q47925916-6C038B3F-8B7D-48E4-A4EB-0D6ECE314192Q48135219-84429D97-A805-42B0-9EF2-025AA86FE6AAQ52621890-ECE186B9-B0E1-467D-B5FE-90AA0A6D5667Q52656684-BB480748-CD05-44F1-92B1-2F21C3D0A7F9Q55431520-1E976356-C298-4542-8215-DF704181B4DA
P2860
The risk of switch to mania in patients with bipolar disorder during treatment with an antidepressant alone and in combination with a mood stabilizer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
The risk of switch to mania in ...... nation with a mood stabilizer.
@en
The risk of switch to mania in ...... nation with a mood stabilizer.
@nl
type
label
The risk of switch to mania in ...... nation with a mood stabilizer.
@en
The risk of switch to mania in ...... nation with a mood stabilizer.
@nl
prefLabel
The risk of switch to mania in ...... nation with a mood stabilizer.
@en
The risk of switch to mania in ...... nation with a mood stabilizer.
@nl
P50
P1476
The risk of switch to mania in ...... nation with a mood stabilizer.
@en
P2093
Michael E Thase
P304
P356
10.1176/APPI.AJP.2014.13111501
P407
P50
P577
2014-10-01T00:00:00Z